US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

CSTONE PHARMACEUTICALS

0.7029

0.0000

Volume:- -

Turnover:- -

Market Cap:1.02B

PE:-71.79

High:0.7029

Open:0.7029

Low:0.7029

Close:0.7029

52wk High:1.00

52wk Low:0.5181

Shares:1.46B

Float Shares:1.03B

Volume Ratio:0.02

T/O Rate:- -

Dividend:- -

Dividend Rate:- -

EPS(TTM):-0.0098

EPS(LYR):-0.0098

ROE:-96.36%

ROA:-16.93%

PB:22.40

PE(LYR):-71.79

Loading ...

Overview Company News Filings

Company Profile

Company Name:

CSTONE PHARMACEUTICALS

Exchange:

PINK LIMITED

Establishment Date:

2015

Employees:

131

Office Location:

C1 Building,No. 218 Xinghu Street,North Block,Suzhou Industrial Park,Suzhou,Jiangsu Province,China

Website:

http://www.cstonepharma.com/en/

Zip Code:

215123

Phone:

86 512 8718 6550

Fax:

- -

Introduction:

CStone Pharmaceuticals, a biopharmaceutical company, researches, develops, and commercializes immuno-oncology and precision medicines to address the unmet medical needs of cancer patients in China and internationally. It offers Sugemalimab, a monoclonal antibody against programmed death (PD) ligand 1; GAVRETO, an RET inhibitor for the treatment of patients with advanced or metastatic RET-mutant medullary and RET fusion-positive thyroid cancers; and avapritinib, a KIT/PDGFRA inhibitor to treat adults with unresectable or metastatic gastrointestinal stromal tumors harboring a PDGFRA exon 18 mutation. The company's product pipeline includes Nofazinlimab, a PD-1 antibody for the treatment of patients with hepatocellular carcinoma; and Ivosidenib, an isocitrate dehydrogenase 1 (IDH1) inhibitor to treat adults with relapsed or refractory acute myeloid leukemia with an IDH1 mutation. Its products also comprise CS1002, CS2006, CS3005, CS2007, CS2008, CS6001, and CS500 for solid tumors; and CS5001 for solid tumors and hematologic malignancies. The company was incorporated in 2015 and is headquartered in Suzhou, China.

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/CSPHF/company"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"CSPHF","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"CSPHF\",,,,,undefined,":{"symbol":"CSPHF","market":"US","secType":"STK","nameCN":"CSTONE PHARMACEUTICALS","latestPrice":0.7029,"timestamp":1771016400000,"preClose":0.7029,"halted":0,"volume":0,"delay":15,"changeRate":0,"floatShares":1026220576,"shares":1457400750,"eps":-0.009791,"marketStatus":"Not Yet Opened","change":0,"latestTime":"02-13 16:00:00 EST Delay","open":0.7029,"high":0.7029,"low":0.7029,"amount":0,"amplitude":0,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"otc":true,"ttmEps":-0.009791,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1771318800000},"marketStatusCode":0,"adr":0,"exchange":"PINK LIMITED","adjPreClose":0.7029,"volumeRatio":0.02484842547430165},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"CSPHF\",,,,,undefined,":{"symbol":"CSPHF","floatShares":1026220576,"roa":"-16.93%","roe":"-96.36%","lyrEps":-0.009791,"volumeRatio":0.02484842547430165,"shares":1457400750,"dividePrice":0,"high":0.7029,"amplitude":0,"preClose":0.7029,"low":0.7029,"week52Low":0.5181,"pbRate":"22.40","psRate":"34.85","week52High":1,"institutionHeld":0,"latestPrice":0.7029,"eps":-0.009791,"divideRate":0,"volume":0,"delay":15,"ttmEps":-0.009791,"open":0.7029,"prevYearClose":0.893,"prevWeekClose":0.7029,"prevMonthClose":0.7191,"prevQuarterClose":0.893,"fiveDayClose":0.7191,"twentyDayClose":0.8584,"sixtyDayClose":0.893},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/CSPHF\",params:#limit:5,,,undefined,":[{"date":"2023-08-15","symbol":"CSPHF","type":"earning","reportTimeType":"post","market":"US","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1692129600000,"name":null,"time":"Post Market","dateTimestamp":1692072000000,"actualEps":null},{"market":"US","date":"2022-08-25","symbol":"CSPHF","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1661400000000,"reportTimeType":"pre","actualEps":null}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"CSPHF\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"CSPHF\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.5,"buy":0.5,"hold":0,"sell":0,"strongSell":0,"meanLabel":"STRONG BUY","meanPercent":0.5,"analysts":2,"updateTime":1761109200000},"@#url:\"stock.company.info\",,undefined,":{"stockCompanyProfile":{"companyId":602087748,"yearFounded":2015,"employeeNum":131,"address":"C1 Building,No. 218 Xinghu Street,North Block,Suzhou Industrial Park,Suzhou,Jiangsu Province,China","zipCode":"215123","officePhone":"86 512 8718 6550"},"stockCompanyDetail":{"websiteUrl":"http://www.cstonepharma.com/en/","description":"CStone Pharmaceuticals, a biopharmaceutical company, researches, develops, and commercializes immuno-oncology and precision medicines to address the unmet medical needs of cancer patients in China and internationally. It offers Sugemalimab, a monoclonal antibody against programmed death (PD) ligand 1; GAVRETO, an RET inhibitor for the treatment of patients with advanced or metastatic RET-mutant medullary and RET fusion-positive thyroid cancers; and avapritinib, a KIT/PDGFRA inhibitor to treat adults with unresectable or metastatic gastrointestinal stromal tumors harboring a PDGFRA exon 18 mutation. The company's product pipeline includes Nofazinlimab, a PD-1 antibody for the treatment of patients with hepatocellular carcinoma; and Ivosidenib, an isocitrate dehydrogenase 1 (IDH1) inhibitor to treat adults with relapsed or refractory acute myeloid leukemia with an IDH1 mutation. Its products also comprise CS1002, CS2006, CS3005, CS2007, CS2008, CS6001, and CS500 for solid tumors; and CS5001 for solid tumors and hematologic malignancies. The company was incorporated in 2015 and is headquartered in Suzhou, China.","exchange":"PINK LIMITED","name":"CSTONE PHARMACEUTICALS","nameEN":"CSTONE PHARMACEUTICALS"}},"@#url:\"https://hq.skytigris.cn/fundamental/company/manager/list\",params:#symbol:\"CSPHF\",market:\"US\",,,undefined,":null}}